Breadcrumb
  1. Home
  2. Data & Reporting
  3. Health Center COVID-19 Survey

Health Center COVID-19 Survey

National Summary Report

Latest data from August 2023

HRSA uses the information collected to: optimize COVID-19 testing and vaccination; track health center capacity and the impact of COVID-19 on operations, patients, and staff; and better understand training and technical assistance, funding, and other health center resource needs.

Health Center COVID-19 Survey Tool Questions

Health Center COVID-19 Survey Tool User Guide

Health Center Program Look-Alike Survey Data for COVID-19

Number of Health Center respondents = 920 (67% of all Health Centers)

Data represents information provided by health centers funded through H80 grants from a single, specified monthly reporting date as indicated above. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Survey Results

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen) 179,701
COVID-19 Vaccination Doses Administered

11,625

Percent of COVID-19 Vaccination Doses Administered to Racial and Ethnic Minorities 78.36%
Percent of Health Centers Hosting Community-Based Events (Mobile Vans, Pop-Up Clinics, School-Based Sites, or Family Vaccination Clinics) 22.17%
Number of Community-Based Events 1,524
Number of Collaboration Community-Based Events 599
Percent of Health Centers Administer Vaccines from Vaccine Program 19.35%
Percent of Health Centers Distribute Test Kits from HRSA 41.30%
Percent of Health Centers Distribute Oral Antiviral Medication from HRSA 23.59%
COVID-19 Vaccination Doses Administered Through Health Center COVID-19 Vaccine Program 11,625
Percent of Health Center COVID-19 Vaccine Program Doses Administered to Racial and Ethnic Minorities 78.36%
Percent of Health Center COVID-19 Vaccine Program Doses Administered to Special Populations 78.95%
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 146,315
Number of Patients Who Received COVID-19 Oral Antiviral Medication 4,349
Percent of COVID-19 Oral Antiviral Medications Given to Racial and Ethnic Minorities 77.78%
Percent of COVID-19 Oral Antiviral Medications Given to Special Populations 50.72%
Date Last Reviewed: